Area of research
Radiology, Nuclear Medicine and Imaging · Cancer Research
Research interest
Research interests include Gut flora, Immune system, Immunotherapy, Cancer research, Metformin, and Cell biology.
NRT1.1B acts as an abscisic acid receptor in integrating compound environmental cues for plants
Gut microbiota-derived UDCA enhanced by metformin inhibits FXR to activate autophagy against MCD diet-induced NAFLD in mice
Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis
Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis
Prevotella histicola Mitigated Estrogen Deficiency-Induced Depression via Gut Microbiota-Dependent Modulation of Inflammation in Ovariectomized Mice
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology
IMMU-14. THERAPEUTIC MODULATION OF THE PHAGOCYTIC AXIS SPARKS ANTI-TUMOR CD8 T CELL RESPONSES IN GLIOBLASTOMA
Designing nanomedicine for immuno-oncology
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes